BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-973@pharmaconomics
DTSTAMP:20260707T034933Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:DYN Phase 3 — z-basivarsen (estimated date)
DESCRIPTION:Phase 3 trial results for z-basivarsen in Myotonic Dystrophy Type 1 (DM1) are due ~ Jan 1\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1818794/000119312526215720/dyn-ex99_1.htm\n\nTrack it: https://www.pharmaconomics.com/e/973
URL:https://www.pharmaconomics.com/e/973
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:DYN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR